Report Detail
Global Non-Invasive Cancer Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4736021 |
- 24 August, 2026 |
- Global |
- 96 Pages |
- GIR |
- Service & Software
According to our (Global Info Research) latest study, the global Non-Invasive Cancer Detection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.
This report is a detailed and comprehensive analysis for global Non-Invasive Cancer Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Invasive Cancer Detection market size and forecasts, in consumption value ($ Million), 2021-2032
Global Non-Invasive Cancer Detection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Non-Invasive Cancer Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Non-Invasive Cancer Detection market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Invasive Cancer Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Cancer Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Non-Invasive Cancer Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Imaging Test
Nuclear Medicine Test
Others
Market segment by Application
Prostate Cancer
Bladder Cancer
Pancreatic Cancer
Breast Cancer
Gastric Cancer
Others
Market segment by players, this report covers
Trublood
Datar Cancer Genetics
Nucleix
miR Scientific
Owlstone Medical
bioAffinity Technologies
Nonacus
Amadix
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Non-Invasive Cancer Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Invasive Cancer Detection, with revenue, gross margin, and global market share of Non-Invasive Cancer Detection from 2021 to 2026.
Chapter 3, the Non-Invasive Cancer Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Non-Invasive Cancer Detection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Cancer Detection.
Chapter 13, to describe Non-Invasive Cancer Detection research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Non-Invasive Cancer Detection by Type
- 1.3.1 Overview: Global Non-Invasive Cancer Detection Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Non-Invasive Cancer Detection Consumption Value Market Share by Type in 2025
- 1.3.3 Imaging Test
- 1.3.4 Nuclear Medicine Test
- 1.3.5 Others
- 1.4 Global Non-Invasive Cancer Detection Market by Application
- 1.4.1 Overview: Global Non-Invasive Cancer Detection Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Prostate Cancer
- 1.4.3 Bladder Cancer
- 1.4.4 Pancreatic Cancer
- 1.4.5 Breast Cancer
- 1.4.6 Gastric Cancer
- 1.4.7 Others
- 1.5 Global Non-Invasive Cancer Detection Market Size & Forecast
- 1.6 Global Non-Invasive Cancer Detection Market Size and Forecast by Region
- 1.6.1 Global Non-Invasive Cancer Detection Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Non-Invasive Cancer Detection Market Size by Region, (2021-2032)
- 1.6.3 North America Non-Invasive Cancer Detection Market Size and Prospect (2021-2032)
- 1.6.4 Europe Non-Invasive Cancer Detection Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Non-Invasive Cancer Detection Market Size and Prospect (2021-2032)
- 1.6.6 South America Non-Invasive Cancer Detection Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Non-Invasive Cancer Detection Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Trublood
- 2.1.1 Trublood Details
- 2.1.2 Trublood Major Business
- 2.1.3 Trublood Non-Invasive Cancer Detection Product and Solutions
- 2.1.4 Trublood Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Trublood Recent Developments and Future Plans
- 2.2 Datar Cancer Genetics
- 2.2.1 Datar Cancer Genetics Details
- 2.2.2 Datar Cancer Genetics Major Business
- 2.2.3 Datar Cancer Genetics Non-Invasive Cancer Detection Product and Solutions
- 2.2.4 Datar Cancer Genetics Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Datar Cancer Genetics Recent Developments and Future Plans
- 2.3 Nucleix
- 2.3.1 Nucleix Details
- 2.3.2 Nucleix Major Business
- 2.3.3 Nucleix Non-Invasive Cancer Detection Product and Solutions
- 2.3.4 Nucleix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Nucleix Recent Developments and Future Plans
- 2.4 miR Scientific
- 2.4.1 miR Scientific Details
- 2.4.2 miR Scientific Major Business
- 2.4.3 miR Scientific Non-Invasive Cancer Detection Product and Solutions
- 2.4.4 miR Scientific Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 miR Scientific Recent Developments and Future Plans
- 2.5 Owlstone Medical
- 2.5.1 Owlstone Medical Details
- 2.5.2 Owlstone Medical Major Business
- 2.5.3 Owlstone Medical Non-Invasive Cancer Detection Product and Solutions
- 2.5.4 Owlstone Medical Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Owlstone Medical Recent Developments and Future Plans
- 2.6 bioAffinity Technologies
- 2.6.1 bioAffinity Technologies Details
- 2.6.2 bioAffinity Technologies Major Business
- 2.6.3 bioAffinity Technologies Non-Invasive Cancer Detection Product and Solutions
- 2.6.4 bioAffinity Technologies Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 bioAffinity Technologies Recent Developments and Future Plans
- 2.7 Nonacus
- 2.7.1 Nonacus Details
- 2.7.2 Nonacus Major Business
- 2.7.3 Nonacus Non-Invasive Cancer Detection Product and Solutions
- 2.7.4 Nonacus Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Nonacus Recent Developments and Future Plans
- 2.8 Amadix
- 2.8.1 Amadix Details
- 2.8.2 Amadix Major Business
- 2.8.3 Amadix Non-Invasive Cancer Detection Product and Solutions
- 2.8.4 Amadix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Amadix Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Non-Invasive Cancer Detection Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Non-Invasive Cancer Detection by Company Revenue
- 3.2.2 Top 3 Non-Invasive Cancer Detection Players Market Share in 2025
- 3.2.3 Top 6 Non-Invasive Cancer Detection Players Market Share in 2025
- 3.3 Non-Invasive Cancer Detection Market: Overall Company Footprint Analysis
- 3.3.1 Non-Invasive Cancer Detection Market: Region Footprint
- 3.3.2 Non-Invasive Cancer Detection Market: Company Product Type Footprint
- 3.3.3 Non-Invasive Cancer Detection Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Non-Invasive Cancer Detection Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Non-Invasive Cancer Detection Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Non-Invasive Cancer Detection Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Non-Invasive Cancer Detection Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Non-Invasive Cancer Detection Consumption Value by Type (2021-2032)
- 6.2 North America Non-Invasive Cancer Detection Market Size by Application (2021-2032)
- 6.3 North America Non-Invasive Cancer Detection Market Size by Country
- 6.3.1 North America Non-Invasive Cancer Detection Consumption Value by Country (2021-2032)
- 6.3.2 United States Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 6.3.3 Canada Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Non-Invasive Cancer Detection Consumption Value by Type (2021-2032)
- 7.2 Europe Non-Invasive Cancer Detection Consumption Value by Application (2021-2032)
- 7.3 Europe Non-Invasive Cancer Detection Market Size by Country
- 7.3.1 Europe Non-Invasive Cancer Detection Consumption Value by Country (2021-2032)
- 7.3.2 Germany Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 7.3.3 France Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 7.3.5 Russia Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 7.3.6 Italy Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Non-Invasive Cancer Detection Market Size by Region
- 8.3.1 Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Region (2021-2032)
- 8.3.2 China Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 8.3.3 Japan Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 8.3.5 India Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 8.3.7 Australia Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Non-Invasive Cancer Detection Consumption Value by Type (2021-2032)
- 9.2 South America Non-Invasive Cancer Detection Consumption Value by Application (2021-2032)
- 9.3 South America Non-Invasive Cancer Detection Market Size by Country
- 9.3.1 South America Non-Invasive Cancer Detection Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Non-Invasive Cancer Detection Market Size by Country
- 10.3.1 Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
- 10.3.4 UAE Non-Invasive Cancer Detection Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Non-Invasive Cancer Detection Market Drivers
- 11.2 Non-Invasive Cancer Detection Market Restraints
- 11.3 Non-Invasive Cancer Detection Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Non-Invasive Cancer Detection Industry Chain
- 12.2 Non-Invasive Cancer Detection Upstream Analysis
- 12.3 Non-Invasive Cancer Detection Midstream Analysis
- 12.4 Non-Invasive Cancer Detection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Non-Invasive Cancer Detection. Industry analysis & Market Report on Non-Invasive Cancer Detection is a syndicated market report, published as Global Non-Invasive Cancer Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-Invasive Cancer Detection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
